In March 2018, Wenzhou Kangning Hospital filed its application to start an International Academician Workstation. On March 20, 2020, the Organization Department of Wenzhou Municipal Party Committee and Wenzhou Association of Science and Technology jointly approved the founding the workstation. The Workstation has welcomed academicians from the Royal College of Art and from Canadian Academy of Health Sciences. The multifaceted goals of this platform entail in-depth development in medical technology innovation, AI application in psychiatry, basic and clinical research in Alzheimer's disease, medical education, and children & adolescents mental health.
Through project cooperation and management, academician technical consultation and research results transformation, the Academician Workstation strives to provide Kangning Hospital Group with an access to international resources, a broader international horizon, cutting-edge information and medical innovation resources. These all help enhance Kangning's professional competence and empower Kangning to achieve higher level of excellence. The Workstation has been well endorsed and supported by government of all levels. These district-, city- and higher-level government agencies demonstrate their support through matching financial resources. The workstation has developed close partnership with The Institute of Advanced Mental Health Research of Wenzhou Medical University.
The Workstation has welcomed three academicians including Andrew James Greenshaw from the Royal College of Art. The executive management teams consists of the Board of Councilors, Director-from-Overseas, Director-from-Kangning, Strategic Consultants, Associate Director for Administrative Affairs, and associate directors for individuals projects. Dr. Andrew James Greenshaw served as the Director-from-Overseas and Dr. Minjie Ye (Vice President of Wenzhou Kangning Hospital) Director-from-Kangning. Dr. Xin-Min Li (Associate Dean of Faculty of Medicine and Dentistry, University of Alberta) serves as the Strategic-Consultant-from-Overseas.
Introduction to academicians
Andrew James Greenshaw
Andrew James Greenshaw, a Fellow of the Royal College of Art, Professor of Psychiatry and Neuroscience, Faculty of Medicine and Dentistry; Associate Chair (Research) of University of Alberta, Canada. Director, Canadian Depression and Research Intervention Network (CDRIN), Scientific Director of the APEC Digital Hub for Mental Health, member of the Advisory Board of the CIHR Institute for Neuroscience, Mental Health and Addictions. Main research interest focuses on AI in psychiatry, digital solutions in mental health and e-health technology.
Dr. Greenshaw is an internationally renowned scholar in psychiatry. Andy has been active in teaching and research and has extensive experiences in numerous areas, including addiction mechanisms, behavioral and functional neuroimaging, and depression. He has won a number of awards including CCNP Young Investigator Award, CINP Rafaelson Scholar, CCNP Janssen Innovations Award in Neuropsychopharmacology. He is also the recipient of numerous research awards from Alberta Heritage Foundation for Medical Research, the Canadian Psychiatric Research Foundation, the Alberta Mental Health Research Fund, the Alberta Centre for Child Family and Community Research and the Norlien Foundation.
Canada Research Chair in Alzheimer's Disease; Professor and Associate Director, Institute of Mental Health, University of British Columbia (UBC); Senior Advisor to the UBC President on China;
Dr. Song received his medical degree from Chongqing Medical University in 1983. After completing his Master of Medicine degree at West China University of Medical Sciences in 1986, he then stayed in the university and became an attending psychiatrist and a Lecturer of Psychiatry. Dr. Song obtained a MSc in psychobiology and behavioral genetics from Purdue University in 1993 and a PhD in medical neurobiology and molecular genetics at Indiana University School of Medicine in 1996. He received his postdoctoral training at Harvard Medical School (1996-99) and worked as an Instructor at Harvard Medical School (1999-2001). Dr. Song joined UBC in 2001.
Dr. Song has been dedicated for many years to the research of Alzheimer's Disease. He was elected to Fellowship in the Canadian Academy of Health Sciences (CAHS) in 2012. He was a recipient of the National Science Fund for Outstanding Young Scholars (Type B, 2005), the “Changjiang Chaired Professor” Award (2006)”, “Thousand Talent Program” Award (2011) and “Friendship Award” (2011). He was invited as a distinguished overseas representative for the 12th Chinese People's Political Consultative Conference and elected as a “Beijing Overseas Talent Aggregation Project” Strategic Scientist.
Dr. Song officially joined Kangning in July 2020. As the Chief Scientist in Psychiatry, Dr. Song is to work with Wenzhou Medical University and start the Alzheimer Research Center and Research Institute on Geriatric Brain Illness
Part of Dr. Song’s Research Agenda:
1. Etiology of AD: congenital etiology and acquired etiology
2. Pathogenesis of AD
3. Early diagnosis of AD, including the application of artificial intelligence and big data technology in AD research
4. AD medication
5. Non-pharmaceutical treatment
6. Prevention of AD and Sociological Response to Aging
7. Sociological response to aging
8. Platform development
Projects and Achievements
The Academician Workstation’s work has achieved positive outcomes since its beginning.
1) moving toward the direction to build an intelligent hospital, a three-party-partnership has been formed among Kangning’s subsidiary - Jeremiah Information Technology Co., Ltd., the University of Alberta in Canada (ranked third globally in AI) and AltaML Inc., the largest machine learning company in West Canada for the Development & Application of Clinical Decision Support System for Mental Disorders. This project has been awarded by Zhejiang Provincial Department of Science and Technology as a Key R&D Program project. Kangning has also been accredited as the Zhejiang International Collaboration Base for Science and Technology (International Collaboration Base for Digital Psychiatry and Alzheimer's Disease).
2) China has yet to see a standardized medical education model or system for the field of mental healthcare. Kangning, as an accredited clinical teaching base at national and provincial levels and for numerous universities in standardized residency training and clinical practices, is to take the lead by introducing international models in medical education and standardized residency training. It also sets to send out its outstanding teachers and students overseas for further study. In cooperation with Wenzhou Medical University, Kangning has already sent out clinicians to University of Alberta Canada for medical education study and training. In the future, more administrative and medical staff members will be sent out for international visit and training opportunities;
3) In terms of medical technology innovation, Kangning will bring in more international cutting-edge technologies, including US patented technology.
Since the founding the Workstation, Kangning has conducted numerous and diverse exchange visits, in-depth discussions and studies with Canadian academicians, partners and experts.
Weili Guan, the Chairman of the Board, joined Zhejiang Provincial Department of Science and Technology delegation with Kangning team to attend Inventures 2019 held by Alberta Innovates.
President Lianyun Wang led the Kangning team to visit the University of Alberta, University of Alberta Hospital, and CASA Child, Adolescent and Family Mental Health Center.
International academicians and scholars visiting Kangning for collaborative meetings and exchange on scientific research and innovation